These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26004416)

  • 1. PPARδ signaling regulates colorectal cancer.
    You M; Yuan S; Shi J; Hou Y
    Curr Pharm Des; 2015; 21(21):2956-9. PubMed ID: 26004416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells.
    Wang D; Ning W; Xie D; Guo L; DuBois RN
    Oncogene; 2012 Feb; 31(8):1013-23. PubMed ID: 21765467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
    Handeli S; Simon JA
    Mol Cancer Ther; 2008 Mar; 7(3):521-9. PubMed ID: 18347139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting peroxisome proliferator-activated receptor-β/δ in colon cancer: how to aim?
    Xu M; Zuo X; Shureiqi I
    Biochem Pharmacol; 2013 Mar; 85(5):607-611. PubMed ID: 23041232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of mTOR, PPARγ and PPARδ signaling in regulating early pregnancy decidual function, embryo viability and feto-placental growth.
    Roberti SL; Higa R; White V; Powell TL; Jansson T; Jawerbaum A
    Mol Hum Reprod; 2018 Jun; 24(6):327-340. PubMed ID: 29538677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of porcine peroxisome proliferator-activated receptor delta regulates adipogenesis in mouse myoblasts.
    Yu YH; Wu SC; Cheng WT; Mersmann HJ; Ding ST
    J Anim Sci; 2008 Jan; 86(1):64-72. PubMed ID: 17878286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin suppresses PPARdelta expression and related genes in HT-29 cells.
    Wang JB; Qi LL; Zheng SD; Wang HZ; Wu TX
    World J Gastroenterol; 2009 Mar; 15(11):1346-52. PubMed ID: 19294764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
    Gupta RA; Tan J; Krause WF; Geraci MW; Willson TM; Dey SK; DuBois RN
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13275-80. PubMed ID: 11087869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin-induced apoptosis in jurkat cells is not mediated by peroxisome proliferator-activated receptor delta.
    López JM; Fernández MA; Piqué M; Gil J
    Mol Cell Biochem; 2004 Nov; 266(1-2):57-63. PubMed ID: 15646027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
    Park JH; Lee KS; Lim HJ; Kim H; Kwak HJ; Park HY
    J Cell Biochem; 2012 Jun; 113(6):1947-54. PubMed ID: 22234939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-activated PPARδ upregulates α-smooth muscle actin expression in human dermal fibroblasts: A potential role for PPARδ in wound healing.
    Ham SA; Hwang JS; Yoo T; Lee WJ; Paek KS; Oh JW; Park CK; Kim JH; Do JT; Kim JH; Seo HG
    J Dermatol Sci; 2015 Dec; 80(3):186-95. PubMed ID: 26481780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
    Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of a lentiviral vector of RNA interference against PPARS gene and the establishment of colon cancer cell line KM12C with stable knockdown of PPARdelta expression].
    Jiang X; Yang L; Zhou Z; Li Y; Wang L; Yu Y; Wang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):400-6. PubMed ID: 20481327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V.
    Aberle J; Hopfer I; Beil FU; Seedorf U
    Int J Obes (Lond); 2006 Dec; 30(12):1709-13. PubMed ID: 16652134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators and nuclear receptor signaling in colorectal cancer.
    Wang D; DuBois RN
    Cell Cycle; 2007 Mar; 6(6):682-5. PubMed ID: 17374999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
    Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
    Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
    Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
    Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
    Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
    Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells.
    Zaveri NT; Sato BG; Jiang F; Calaoagan J; Laderoute KR; Murphy BJ
    Cancer Biol Ther; 2009 Jul; 8(13):1252-61. PubMed ID: 19633434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.